搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
11 小时
MeiraGTx Holdings: Promising Growth Potential with Strategic Manufacturing and Positive ...
Alec Stranahan, an analyst from Bank of America Securities, maintained the Buy rating on Meiragtx Holdings (MGTX – Research Report). The ...
precisionmedicineonline
14 小时
MeiraGTx to Discuss Parkinson's Gene Therapy Data With Regulators, Planning Phase III Trial
The company said the latest positive safety, tolerability, and efficacy data will underpin discussions with regulators in the US, Europe, and Japan.
14 小时
MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?
MeiraGTx (MGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Zacks.com on MSN
16 小时
MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study
MeiraGTx Holdings’ MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson’s disease (PD) ...
18 小时
MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results
MeiraGTx Holdings has unveiled promising results from its clinical bridging study of AAV-GAD, a gene therapy for Parkinson’s ...
bovnews
19 小时
MeiraGTx Holdings PLC (MGTX) Stock: Greater Than Its Current Valuation?
On Tuesday, MeiraGTx Holdings PLC (MGTX) stock saw a modest uptick, ending the day at $5.33 which represents a slight increase of $0.69 or 14.87% from the prior close of $4.64. The stock opened at $5.
pharmaphorum
21 小时
MeiraGTx plans to take Parkinson's gene therapy into phase 3
According to MeiraGTx, AAV-GAD is designed to reprogramme dysfunctional circuits in the Parkinson's brain through the local ...
1 天
MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings
Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...
1 天
Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant ...
MeiraGTx's clinical study of AAV-GAD for Parkinson's disease showed significant improvements in motor function and quality of ...
ENDPOINTS NEWS
1 天
MeiraGTx's stock rises on small Parkinson's gene therapy dataset
MeiraGTx unveiled results from a small dataset for its Parkinson’s disease gene therapy on Tuesday morning, causing its ...
1 天
Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving ...
Walgreens reported fourth-quarter fiscal year 2024 sales of $37.55 billion, up 6% year over year (+6.1% on constant currency) ...
The Pharma Letter
1 天
MeiraGTx rises on positive study of AAV-GAD for Parkinson’s disease
US clinical-stage genetic meds company MeiraGTx Holdings has released positive top-line data from its clinical bridging study ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈